Evidence map›Paper›PMID 42639728›Full record

ReviewJournal of food science2026

Advances in Xylooligosaccharides Production From Lignocellulosic Materials and Its Application as Prebiotics.

Paula Cavion Costa, Marli Camassola

Abstract readReview
In one paragraph

Review in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paula Cavion CostaEnzymes and Biomasses Laboratory, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.ORCID https://orcid.org/0000-0001-5709-2020
Marli CamassolaEnzymes and Biomasses Laboratory, University of Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e TecnológicoCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFundação de Amparo à Pesquisa do Estado do Rio Grande do SulUniversity of Caxias do Sul
6 · The paper itself

Abstract

With the growing interest in functional foods and their role in promoting health beyond basic nutrition, increasing attention has been directed toward the modulation of gut microbiota as a key determinant of human well-being. In this context, prebiotics and probiotics have emerged as central bioactive ingredients due to their capacity to selectively influence microbial composition and metabolic activity in the gastrointestinal tract. Prebiotics are defined as nondigestible food components that are selectively utilized by beneficial microorganisms, leading to improved host health, whereas probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. This review explores the mechanisms of action, major sources, and documented health effects of both prebiotics and probiotics, with particular emphasis on their roles in digestive health, immune modulation, and the prevention or management of metabolic and inflammatory disorders. Special attention is given to xylooligosaccharides (XOS) as emerging prebiotics derived from lignocellulosic biomass, highlighting recent advances in enzymatic production processes using microbial enzymes, especially fungal xylanases. Furthermore, the paper discusses current biotechnological strategies for sustainable production, purification, and formulation of prebiotic and probiotic ingredients, as well as the growing evidence supporting their synergistic interaction when combined as synbiotics. Understanding the complex interplay between prebiotics, probiotics, and the gut microbiota is essential for the rational design of next-generation functional foods and dietary interventions aimed at improving human health.

Indexed as

GlucuronatesLigninOligosaccharidesPrebioticsFunctional FoodGastrointestinal MicrobiomeHumansProbioticsGlucuronatesLigninlignocelluloseOligosaccharidesPrebioticsxylooligosaccharide

Identifiers

PMID42639728
PMCPMC13504636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.